1
|
Wiethoff I, Goversen B, Michels M, van der Velden J, Hiligsmann M, Kugener T, Evers SMAA. A systematic literature review of economic evaluations and cost-of-illness studies of inherited cardiomyopathies. Neth Heart J 2023; 31:226-237. [PMID: 37171710 DOI: 10.1007/s12471-023-01776-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/03/2023] [Indexed: 05/13/2023] Open
Abstract
Hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) are commonly inherited heart conditions associated with a high risk of heart failure and sudden cardiac death. To understand the economic and societal disease burden, this study systematically identified and reviewed cost-of-illness (COI) studies and economic evaluations (EEs) of various interventions for HCM and DCM. A literature search was performed in MEDLINE, EMBASE, NHS EED, EconLit and Web of Science to identify COI studies and EEs published between 1 January 2010 and 28 April 2021. The selection of studies and their critical appraisal were performed jointly by two independent researchers. For the quality assessment, the 'Consensus on Health Economic Criteria' list was used. Two COI studies and 11 EEs were eligible for inclusion. Cost-effectiveness varied among interventions and depended on the targeted patient population. Both COI studies identified only hospitalisation costs in HCM. The mean study quality was high in EEs but low in COI studies. Most studies excluded costs for patients, caregivers and productivity losses. Overall, knowledge of the societal and economic burden of inherited cardiomyopathies is limited. Future research needs to include quality-adjusted life years and a broader range of costs to provide an information base for optimising care for affected patients.
Collapse
Affiliation(s)
- Isabell Wiethoff
- Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
| | - Birgit Goversen
- Department of Physiology, Amsterdam UMC, Vrije Universiteit, Amsterdam Cardiovascular Sciences Institute, Amsterdam, The Netherlands
| | - Michelle Michels
- Department of Cardiology, Thoraxcenter, Erasmus MC Rotterdam, Rotterdam, The Netherlands
| | - Jolanda van der Velden
- Department of Physiology, Amsterdam UMC, Vrije Universiteit, Amsterdam Cardiovascular Sciences Institute, Amsterdam, The Netherlands
| | - Mickaël Hiligsmann
- Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands
| | - Tom Kugener
- Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands
| | - Silvia M A A Evers
- Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands
- Centre for Economic Evaluation and Machine Learning, Trimbos Institute, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands
| |
Collapse
|
2
|
Pujalte GGA, Narducci DM, Smith MS, King R, Logan K, Callender SS, Liebman CA, Kane SF, Israel MP, Wolf SF, Nuti R, Khodaee M. Athletes With Attention-Deficit/Hyperactivity Disorder: Position Statement of the American Medical Society for Sports Medicine. Clin J Sport Med 2023; 33:195-208. [PMID: 37185161 DOI: 10.1097/jsm.0000000000001152] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/24/2023] [Accepted: 03/28/2023] [Indexed: 05/17/2023]
Abstract
ABSTRACT Athletes of all ages may be affected by medical and mental health issues. Sports medicine physicians should be familiar with common conditions that may affect the well-being of athletes, such as attention-deficit/hyperactivity disorder (ADHD). ADHD behaviors have the potential to affect a person's ability to concentrate. It is likely that social and cognitive therapies combined with pharmacotherapy will be the most effective way to treat ADHD in athletes. Medications used for ADHD, especially stimulant types, are known to improve alertness, reaction time, anaerobic performance, and endurance, which would potentially improve athletic performance. Furthermore, stimulant medications may enable student athletes with ADHD to focus on academic studies for longer periods of time, beyond usual levels of fatigue, important for those who may be exhausted after practices and games. The purported performance enhancement effects and potential adverse effects of stimulant medications have prompted many sports governing bodies to ban prescription stimulants or establish strict rules for their use. Athletes taking physician-prescribed stimulants to treat ADHD need to provide the appropriate documentation for approval before competition or risk punitive measures. Physicians should strive to provide a high quality of care to athletes with ADHD through early diagnosis, appropriate and careful multidisciplinary treatment, and complete and timely documentation to facilitate continued sports participation.
Collapse
Affiliation(s)
- George G A Pujalte
- Department of Family Medicine and Department of Orthopedic Surgery, Mayo Clinic, Jacksonville, Florida
| | - Dusty Marie Narducci
- Department of Family Medicine, University of South Florida College of Medicine, Tampa, Florida
| | - Michael Seth Smith
- Sports Medicine Institute, Department of Orthopaedics, Florida Health, Gainesville, Florida
| | - Rebecca King
- Primary Care National Landing, Virginia Hospital Center, Arlington, Virginia
| | - Kelsey Logan
- Division of Sports Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
| | - Shelley Street Callender
- Departments of Pediatrics and Family Medicine, Mercer University School of Medicine, Macon, Georgia
| | - Catherine A Liebman
- Department Family Medicine and Community Health, Penn Health, Philadelphia, Pennsylvania
| | - Shawn F Kane
- Department of Family Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina
| | - Michael P Israel
- Department of Orthopaedic Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas
| | - Sigrid F Wolf
- Division of Orthopaedic Surgery and Sports Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
| | | | - Morteza Khodaee
- AF Williams Family Medicine Clinic, UCHealth, Denver, Colorado
| |
Collapse
|
3
|
MacLachlan H, Dhutia H, Bhatia R, Boden K, Forenc K, Basu J, Miles C, Osborne R, Chandra N, Malhotra A, Stuart G, Peirce N, Sharma S, Papadakis M. Results of a nationally implemented cardiac screening programme in elite cricket players in England and Wales. J Sci Med Sport 2021; 25:287-292. [PMID: 35016820 DOI: 10.1016/j.jsams.2021.12.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2021] [Revised: 11/30/2021] [Accepted: 12/05/2021] [Indexed: 01/02/2023]
Abstract
OBJECTIVES We assessed the diagnostic yield and costs of an electrocardiogram-based national screening programme in elite cricket players and the incremental value of transthoracic echocardiography and periodic evaluation. DESIGN Cross-sectional study. METHODS Between 2008 and 2019, 1208 cricketers underwent screening with a health questionnaire, 12-lead electrocardiogram and cardiology consultation. Athletes with concerning findings underwent on-site transthoracic echocardiography and further investigations as necessary. In addition, despite a normal health questionnaire and electrocardiogram, 342 (28.3%) athletes had a transthoracic echocardiogram and 493 (40.8%) underwent repeat evaluations. RESULTS After initial evaluation, 47 (3.9%) athletes underwent on-site transthoracic echocardiography of whom 35 (2.8%) were referred for further evaluation. Four athletes (0.3%) were diagnosed with major cardiac conditions; hypertrophic cardiomyopathy (n = 1), arrhythmogenic cardiomyopathy (n = 1) and Wolff-Parkinson-White pattern (n = 2). Two athletes were identified with minor valvular abnormalities. Repeat evaluation of 493 athletes identified hypertrophic cardiomyopathy in a 22-year-old athlete, two years after his initial normal screening. During a follow-up of 5.8 ± 2.9 years no additional diagnoses or adverse cardiac events were reported. The cost of the electrocardiogram-based programme was £127,844, translating to £106 per athlete and £25,569 per major cardiac condition identified.Routine transthoracic echocardiography in 342 athletes identified two athletes with major cardiac conditions (bicuspid aortic valve with severe aortopathy and aortic regurgitation and an atrial septal defect associated with right ventricular volume overload) and 10 athletes with minor abnormalities. CONCLUSIONS An electrocardiogram-based national screening programme identified a major cardiac condition in 0.3% of athletes. Routine transthoracic echocardiography and periodic evaluation increased the diagnostic yield to 0.6%, at an incremental cost.
Collapse
Affiliation(s)
- H MacLachlan
- Cardiovascular Clinical Academic Group, St Georges, University of London, United Kingdom
| | - H Dhutia
- Department of Cardiology, Glenfield Hospital, United Kingdom
| | - R Bhatia
- Cardiovascular Clinical Academic Group, St Georges, University of London, United Kingdom
| | - K Boden
- England and Wales Cricket Board and National Centre for Sports and Exercise Medicine and National Cricket Performance Centre, Loughborough University, United Kingdom
| | - K Forenc
- Cardiovascular Clinical Academic Group, St Georges, University of London, United Kingdom
| | - J Basu
- Cardiovascular Clinical Academic Group, St Georges, University of London, United Kingdom
| | - C Miles
- Cardiovascular Clinical Academic Group, St Georges, University of London, United Kingdom
| | - R Osborne
- Cardiac Risk in the Young, United Kingdom
| | - N Chandra
- Department of Cardiology, Frimley Park Hospital, United Kingdom
| | - A Malhotra
- Division of Cardiovascular Sciences, University of Manchester, United Kingdom
| | - G Stuart
- National Institute of Health Research Cardiovascular Biomedical Research Centre, Bristol Heart Institute, United Kingdom
| | - N Peirce
- England and Wales Cricket Board and National Centre for Sports and Exercise Medicine and National Cricket Performance Centre, Loughborough University, United Kingdom
| | - S Sharma
- Cardiovascular Clinical Academic Group, St Georges, University of London, United Kingdom
| | - M Papadakis
- Cardiovascular Clinical Academic Group, St Georges, University of London, United Kingdom.
| |
Collapse
|
4
|
Petek BJ, Baggish AL. Pre-participation Cardiovascular Screening in Young Competitive Athletes. CURRENT EMERGENCY AND HOSPITAL MEDICINE REPORTS 2021; 8:77-89. [PMID: 33552703 DOI: 10.1007/s40138-020-00214-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Purpose of Review The purpose of this review was to highlight the current recommendations, data, and limitations for methods of cardiovascular screening in athletes. Recent Findings While the history and physical (H&P) alone remains the cornerstone for preparticipation cardiovascular screening (PPCS) in athletes, the advent of modern electrocardiographic (ECG) screening criteria has drastically increased sensitivity and decreased false positive rates for screening. Advanced imaging techniques remain an important component of secondary testing after an athlete has an abnormal initial screening exam, however, the use of imaging for universal screening has not been rigorously tested to date. Current disqualification guidelines have now begun to emphasize shared decision making between the provider and athlete in situations of clinical equipoise. Summary All major medical and sporting societies recommend PPCS using a focused medical history and physical examination for all competitive athletes, but there remains controversy about the role of ECG and advanced imaging in PPCS. Future research should focus on the creation of a randomized trial that is powered for mortality that can truly assess the utility of PPCS in athletes.
Collapse
Affiliation(s)
| | - Aaron L Baggish
- Massachusetts General Hospital Cardiovascular Performance Program
| |
Collapse
|
5
|
Liu HW, Huang LW, Chiu SN, Lue HC, Wu MH, Chen MR, Wang JK. Cardiac Screening for High Risk Sudden Cardiac Death in School-Aged Children. ACTA CARDIOLOGICA SINICA 2020; 36:641-648. [PMID: 33235421 DOI: 10.6515/acs.202011_36(6).20200515a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Background Sudden cardiac death (SCD) is an uncommon but significant cause of death in the young. Citywide cardiac screening of school-aged children has been performed in Taipei since 1989. In this study, we investigate the efficacy of this screening method for identifying those at high risk of SCD. Methods This study analyzed the data from the results of cardiac screening for school-aged children in Taipei from 2003 to 2014. The cardiac screening included: Stage I, questionnaire surveys, simplified phonocardiography test and simplified electrocardiography (ECG) test; Stage II, physical examination and auscultation by a pediatric cardiologist for all children who had abnormal findings in stage I screening; Stage III, referral to a pediatric cardiologist for further examinations. Logistic regression and decision tree analyses were performed. Results A total of 566,447 students were screened, of whom 685 were identified as being at high risk of SCD. The most common causes of being at high risk of SCD included Wolff-Parkinson-White syndrome, long QT syndrome, cardiomyopathy and Marfan's syndrome. Using logistic regression analysis, the simplified ECG test was identified as being the most effective tool (odds ratio = 16.4, p < 0.001) and past history as the second most crucial factor (odds ratio = 3.95, p < 0.001) for detecting a high risk of SCD. Decision tree analysis showed that serial studies with a past history and the simplified ECG test could accurately identify those at high risk of SCD. Conclusions Questionnaire survey and simplified electrocardiography test-based cardiovascular screening in school-aged children can identify those at high risk of SCD.
Collapse
Affiliation(s)
- Hsiu-Wen Liu
- Department of Business Administration, Soochow University
| | | | - Shuenn-Nan Chiu
- Department of Pediatrics, National Taiwan University Hospital and Medical College, National Taiwan University
| | - Hung-Chi Lue
- Department of Pediatrics, National Taiwan University Hospital and Medical College, National Taiwan University
| | - Mei-Hwan Wu
- Department of Pediatrics, National Taiwan University Hospital and Medical College, National Taiwan University
| | - Ming-Ren Chen
- Department of Pediatrics, MacKay Memorial Hospital and Mackay Junior College of Medicine, Nursing, and Management, Taipei, Taiwan
| | - Jou-Kou Wang
- Department of Pediatrics, National Taiwan University Hospital and Medical College, National Taiwan University
| |
Collapse
|
6
|
|
7
|
Bickel T, Gunasekaran P, Murtaza G, Gopinathannair R, Gunda S, Lakkireddy D. Sudden Cardiac Death in Famous Athletes, Lessons Learned, Heterogeneity in Expert Recommendations and Pitfalls of Contemporary Screening Strategies. J Atr Fibrillation 2019; 12:2193. [PMID: 32435342 DOI: 10.4022/jafib.2193] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2019] [Revised: 09/11/2019] [Accepted: 10/12/2019] [Indexed: 01/02/2023]
Abstract
Sudden cardiac death (SCD) in competitive athletes, though relatively uncommon, invariably leads to controversy. Specific limitations of an extensive screening process include lack of robust evidence to support prevention of SCD, poor cost-effectiveness and uncertain downstream implications of a positive screening test. An emerging body of evidence points to enhanced neurologically intact survival to hospital discharge when automated external defibrillators (AEDs) are used in a timely manner following sudden cardiac arrest (SCA). A viable alternative to an expansive screening process could be a robust secondary prevention system comprising of improvements in AED availability, stringent enforcement of CPR training in athletes and trainers to provide timely and effective resuscitation to reduce death following SCA. This strategy could widen the window to diagnose and treat the underlying etiology and prevent recurrence of SCA while also offering financial feasibility. Restricting athletes from competitive sports is a difficult decision for physicians owing to a lack of well-defined cutoffs for acceptable and prohibitive risk from pathology predisposing to SCD, especially in the absence of a protective medico-legal framework. In this review, we highlight a few cases that generated intense scrutiny by the public, media and medical professionals about the efficacy, feasibility and pitfalls of the existing screening process to diagnose cardiovascular pathology predisposing to SCD. Furthermore, contrasting approaches to screening, diagnosis and downstream workup protocols between the European Society of Cardiology and the American Heart Association are analyzed.
Collapse
Affiliation(s)
- Trenton Bickel
- Division of Cardiovascular Disease, University of Kansas Hospital and Medical Center, Kansas City, Kansas
| | - Prasad Gunasekaran
- Division of Cardiovascular Disease, University of Kansas Hospital and Medical Center, Kansas City, Kansas
| | - Ghulam Murtaza
- The Kansas City Heart Rhythm Institute and Research Foundation, Overland Park, Kansas
| | - Rakesh Gopinathannair
- The Kansas City Heart Rhythm Institute and Research Foundation, Overland Park, Kansas
| | - Sampath Gunda
- Division of Cardiology, University of Michigan, Ann Arbor, Michigan
| | - Dhanunjaya Lakkireddy
- The Kansas City Heart Rhythm Institute and Research Foundation, Overland Park, Kansas
| |
Collapse
|
8
|
Abstract
PURPOSE OF REVIEW The optimal approach to screening young people to decrease the risk of sudden death remains unknown. It deserves the passionate attention that researchers, clinicians and families have given it. The new data from January 2018 to July 2019 are reviewed here. RECENT FINDINGS Cardiac findings associated with a risk of sudden death were reported in 0.4% of screened athletes. Well run programs continue report varying sensitivity for screening ECGs (between 86 and 100%). One major article reported a higher incidence of sudden death in young people than has been previously published (6.8/100 000 athletes). SUMMARY The rate of important findings in sophisticated screening programs is approximately 0.4%, suggesting that this is near the population rate of detectable disease in most athletic groups. ECGs are unquestionably capable of detecting disease that can be missed by history and physical, but the performance characteristics of ECGs continue to vary from study to study. In addition, the underlying cost and infrastructure of ECG and echocardiographic screening remains unaddressed by the recent literature. A few small studies have started to look at alternative technology approaches to ECG screening. VIDEO ABSTRACT.
Collapse
|
9
|
Vilardell P, Brugada J, Aboal J, Loma-Osorio P, Falces C, Andrea R, Figueras-Coll M, Brugada R. Characterization of electrocardiographic findings in young students. ACTA ACUST UNITED AC 2018; 73:139-144. [PMID: 30287239 DOI: 10.1016/j.rec.2018.06.036] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2018] [Accepted: 06/26/2018] [Indexed: 12/22/2022]
Abstract
INTRODUCTION AND OBJECTIVES The resting 12-lead electrocardiogram (ECG) has been used in the evaluation of young asymptomatic individuals to detect pre-existing heart disease, but systematic ECG use is controversial and there are no data on this population in our environment. We aimed to determine the prevalence and spectrum of electrocardiographic findings in a population of secondary school students. METHODS We conducted an observational, cross-sectional study of resting ECG findings in all 13 to 14-year-old secondary school students in a region of the province of Gerona between 2009 and 2017. ECG findings were classified into 3 groups according to the modified criteria of Corrado et al.: normal ECG findings, ECG findings suggestive of adaptive changes, and pathologic findings. Students with pathologic ECG findings were referred to a tertiary hospital, and complementary tests were performed according to a pre-established protocol. RESULTS A total of 1911 ECGs were obtained, with a participation rate of 79% of all high school students. In all, 1321 students (69%) had a normal ECG, 554 (29%) showed ECG findings suggestive of adaptive changes, and 36 (2%) had pathologic ECG findings. Among the group with pathologic findings, 5 (14%) had cardiovascular disease. The prevalence of heart disease in this group of asymptomatic secondary school students was 0.3%. CONCLUSIONS One third of the students had ECG findings that were mostly suggestive of physiological adaptation. One seventh of the students with pathologic ECG findings had pre-existing heart disease, although the overall prevalence of pre-existing heart disease was low.
Collapse
Affiliation(s)
- Pau Vilardell
- Servicio de Cardiología, Hospital Universitario Josep Trueta de Girona, Girona, Spain.
| | - Josep Brugada
- Servicio de Cardiología, Instituto del Tórax, Hospital Clínic, Barcelona, Spain
| | - Jaime Aboal
- Servicio de Cardiología, Hospital Universitario Josep Trueta de Girona, Girona, Spain; Departamento de Ciencias Médicas, Facultad de Medicina, Universidad de Girona, Girona, Spain
| | - Pablo Loma-Osorio
- Servicio de Cardiología, Hospital Universitario Josep Trueta de Girona, Girona, Spain; Departamento de Ciencias Médicas, Facultad de Medicina, Universidad de Girona, Girona, Spain
| | - Carlos Falces
- Servicio de Cardiología, Instituto del Tórax, Hospital Clínic, Barcelona, Spain
| | - Rut Andrea
- Servicio de Cardiología, Instituto del Tórax, Hospital Clínic, Barcelona, Spain
| | - Marc Figueras-Coll
- Servicio de Pediatría, Hospital Universitario Josep Trueta de Girona, Girona, Spain
| | - Ramon Brugada
- Servicio de Cardiología, Hospital Universitario Josep Trueta de Girona, Girona, Spain; Departamento de Ciencias Médicas, Facultad de Medicina, Universidad de Girona, Girona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain; Centro de Genética Cardiovascular, Institut d'Investigació Biomèdica de Girona (IDIBGI), Girona, Spain
| |
Collapse
|
10
|
Dhutia H, MacLachlan H. Cardiac Screening of Young Athletes: a Practical Approach to Sudden Cardiac Death Prevention. CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE 2018; 20:85. [PMID: 30155696 PMCID: PMC6132782 DOI: 10.1007/s11936-018-0681-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
PURPOSE OF REVIEW We aim to report on the current status of cardiovascular screening of athletes worldwide and review the up-to-date evidence for its efficacy in reducing sudden cardiac death in young athletes. RECENT FINDINGS A large proportion of sudden cardiac death in young individuals and athletes occurs during rest with sudden arrhythmic death syndrome being recognised as the leading cause. The international recommendations for ECG interpretation have reduced the false-positive ECG rate to 3% and reduced the cost of screening by 25% without compromising the sensitivity to identify serious disease. There are some quality control issues that have been recently identified including the necessity for further training to guide physicians involved in screening young athletes. Improvements in our understanding of young sudden cardiac death and ECG interpretation guideline modification to further differentiate physiological ECG patterns from those that may represent underlying disease have significantly improved the efficacy of screening to levels that may make screening more attractive and feasible to sporting organisations as a complementary strategy to increased availability of automated external defibrillators to reduce the overall burden of young sudden cardiac death.
Collapse
Affiliation(s)
- Harshil Dhutia
- Cardiovascular Sciences Research Centre, St George's University of London, London, UK.
- Department of Cardiology, Glenfield Hospital, Leicester, UK.
| | - Hamish MacLachlan
- Cardiovascular Sciences Research Centre, St George's University of London, London, UK
| |
Collapse
|
11
|
Sumitomo N, Baba R, Doi S, Higaki T, Horigome H, Ichida F, Ishikawa H, Iwamoto M, Izumida N, Kasamaki Y, Kuga K, Mitani Y, Musha H, Nakanishi T, Yoshinaga M, Abe K, Ayusawa M, Hokosaki T, Kato T, Kato Y, Ohta K, Sawada H, Ushinohama H, Yoshiba S, Atarashi H, Hirayama A, Horie M, Nagashima M, Niwa K, Ogawa S, Okumura K, Tsutsui H. Guidelines for Heart Disease Screening in Schools (JCS 2016/JSPCCS 2016) ― Digest Version ―. Circ J 2018; 82:2385-2444. [DOI: 10.1253/circj.cj-66-0153] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
12
|
Grazioli G, Sanz de la Garza M, Vidal B, Montserrat S, Sarquella-Brugada G, Pi R, Til L, Gutierrez J, Brugada J, Sitges M. Prevention of sudden death in adolescent athletes: Incremental diagnostic value and cost-effectiveness of diagnostic tests. Eur J Prev Cardiol 2017; 24:1446-1454. [DOI: 10.1177/2047487317713328] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- Gonzalo Grazioli
- Cardiovascular Institute, Hospital Clinic, University of Barcelona; IDIBAPS, Institute for Biomedical Research August Pi i Sunyer, Spain
| | - Maria Sanz de la Garza
- Cardiovascular Institute, Hospital Clinic, University of Barcelona; IDIBAPS, Institute for Biomedical Research August Pi i Sunyer, Spain
| | - Barbara Vidal
- Cardiovascular Institute, Hospital Clinic, University of Barcelona; IDIBAPS, Institute for Biomedical Research August Pi i Sunyer, Spain
| | - Silvia Montserrat
- Cardiovascular Institute, Hospital Clinic, University of Barcelona; IDIBAPS, Institute for Biomedical Research August Pi i Sunyer, Spain
| | - Georgia Sarquella-Brugada
- Department of Cardiology, Hospital Sant Joan de Deu, University of Barcelona, Esplugues de Llobregat, Spain
| | | | - Lluis Til
- GIRSANE, Consorci Sanitari de Terrassa-Centre d Alt Rendiment, Sant Cugat del Valles, Spain
| | | | - Josep Brugada
- Cardiovascular Institute, Hospital Clinic, University of Barcelona; IDIBAPS, Institute for Biomedical Research August Pi i Sunyer, Spain
| | - Marta Sitges
- Cardiovascular Institute, Hospital Clinic, University of Barcelona; IDIBAPS, Institute for Biomedical Research August Pi i Sunyer, Spain
| |
Collapse
|
13
|
CARDIOVASCULAR SCREENING OF YOUNG ATHLETES: A REVIEW OF ECONOMIC EVALUATIONS. Int J Technol Assess Health Care 2017; 33:76-83. [DOI: 10.1017/s0266462317000162] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Objectives: Some experts have promoted preparticipative cardiovascular screening programs for young athletes and have claimed that such programs were cost-effective without performing a critical analysis of studies supporting this statement. In this systematic review, a critical assessment of economic evaluations on these programs is performed to determine if they really provide value for money.Methods: A systematic review of economic evaluations was performed on December 24, 2014. Web sites of health technology assessment agencies, the Cochrane database of systematic review, the National Health Service Economic Evaluation Database of the Cochrane Library, EMBASE, Medline, Psychinfo, and EconLit were searched to retrieve (reviews of) economic evaluations. No language or time restrictions were imposed and predefined selection criteria were used. Selected studies were critically assessed applying a structured data extraction sheet.Results: Five relevant economic evaluations were critically assessed. Results of these studies were mixed. However, those in favor of screening made (methodological) incorrect choices, of which the most important one was not taking into account a no-screening alternative as comparator. Compared with no screening, other strategies (history and physical examination or history and physical examination plus electrocardiogram) were not considered cost-effective.Conclusions: Results of primary economic evaluations should not be blindly copied without critical assessment. Economic evaluations in this field lack the support of robust evidence. Negative consequences of screening (false positive findings, overtreatment) should also be taken into account and may cause more harm than good. A mass screening of young athletes for cardiovascular diseases does not provide value for money and should be discouraged.
Collapse
|
14
|
Abstract
In the present review, we summarize current approaches to the prevention of sudden cardiac death (SCD) in children and young adults, focusing on age less than 35 years. SCD in the young is rare, but devastating from the societal perspective. While coronary artery disease is the main etiology of SCD in the older age groups, conditions such as cardiomyopathies and electrical channelopathies are more likely to be found in the young. In the majority of younger cases, cardiac arrest can be the first recognized manifestation of the underlying cardiac pathology, although some have experienced cardiovascular symptoms prior to the SCD. Since identification of a cardiac disease is pivotal for implementation of appropriate preventive measures, measures such as electrocardiographic screening in subpopulations such as athletes have been proposed. However, these efforts are impeded by the large number of individuals needed to test in order to find one with cardiac disease, leading to significant rates of false positive findings and high costs. When a high-risk cardiac condition is identified in a young person, measures of lifestyle modification, appropriate medical treatment and ICD implantation in selected individuals based on risk stratification are warranted. Nevertheless, the benefits of lifelong ICD therapy need to be balanced with long-term complications and quality of life.
Collapse
Affiliation(s)
- Aapo L Aro
- Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA.,Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland
| | - Sumeet S Chugh
- Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA
| |
Collapse
|
15
|
Mont L, Pelliccia A, Sharma S, Biffi A, Borjesson M, Brugada Terradellas J, Carré F, Guasch E, Heidbuchel H, La Gerche A, Lampert R, McKenna W, Papadakis M, Priori SG, Scanavacca M, Thompson P, Sticherling C, Viskin S, Wilson M, Corrado D, Lip GYH, Gorenek B, Blomström Lundqvist C, Merkely B, Hindricks G, Hernández-Madrid A, Lane D, Boriani G, Narasimhan C, Marquez MF, Haines D, Mackall J, Manuel Marques-Vidal P, Corra U, Halle M, Tiberi M, Niebauer J, Piepoli M. Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. Eur J Prev Cardiol 2016; 24:41-69. [DOI: 10.1177/2047487316676042] [Citation(s) in RCA: 146] [Impact Index Per Article: 18.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Lluís Mont
- Hospital Clinic, Universitat de Barcelona, Barcelona, Spain
| | | | | | | | - Mats Borjesson
- Inst of Neuroscience and Physiology and Food, Nutrition and Sport Science and Östra University Hospital, Goteborg, Sweden
| | | | | | - Eduard Guasch
- Hospital Clinic, Universitat de Barcelona, Barcelona, Spain
| | | | - André La Gerche
- Baker IDI Heart and Diabetes Institute, Melbourne, Australia
| | | | | | | | | | - Mauricio Scanavacca
- Instituto do Coração (InCor) do Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil
| | | | | | | | | | | | | | | | | | - Bela Merkely
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | | | - Antonio Hernández-Madrid
- Unidad De Arritmias, Servicio De Cardiologia, Hospital Universitario Ramón y Cajal, Madrid, Spain
| | - Deirdre Lane
- Hospital Clinic, Universitat de Barcelona, Barcelona, Spain
- Baker IDI Heart and Diabetes Institute, Melbourne, Australia
| | | | | | - Manlio F Marquez
- Departamento de Electrocardiología, Instituto Nacional de Cardiologia Ignacio Chavez, Tlalpan, Mexico
| | - David Haines
- Department of Cardiovascular Medicine, Beaumont Health System, Royal Oak, MI, USA
| | - Judith Mackall
- University Hospitals Case Medical Center, Cleveland, OH, USA
| | | | - Ugo Corra
- IRCCS Rehabilitation Medical Center, Cardiology Department, Salvatore Maugeri Foundation, Veruno, Italy
| | - Martin Halle
- Prevention and Sports Medicine, Technical University Munich, Munich, Germany
| | | | - Josef Niebauer
- Sports Medicine, Prevention & Rehabilitation, Paracelsus Medical University, Salzburg, Austria
| | | | | |
Collapse
|
16
|
Mont L, Pelliccia A, Sharma S, Biffi A, Borjesson M, Terradellas JB, Carré F, Guasch E, Heidbuchel H, Gerche AL, Lampert R, McKenna W, Papadakis M, Priori SG, Scanavacca M, Thompson P, Sticherling C, Viskin S, Wilson M, Corrado D, Lip GYH, Gorenek B, Lundqvist CB, Merkely B, Hindricks G, Hernández-Madrid A, Lane D, Boriani G, Narasimhan C, Marquez MF, Haines D, Mackall J, Marques-Vidal PM, Corra U, Halle M, Tiberi M, Niebauer J, Piepoli M. Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. Europace 2016; 19:139-163. [PMID: 27815371 DOI: 10.1093/europace/euw243] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
Affiliation(s)
- Lluís Mont
- Hospital Clinic, Universitat de Barcelona, Barcelona, Spain
| | | | | | | | - Mats Borjesson
- Inst of Neuroscience and Physiology and Food, Nutrition and Sport Science and Östra University Hospital, Göteborg, Sweden
| | | | | | - Eduard Guasch
- Hospital Clinic, Universitat de Barcelona, Barcelona, Spain
| | | | - André La Gerche
- Baker IDI Heart and Diabetes Institute, Melbourne, Australia
| | | | | | | | | | - Mauricio Scanavacca
- Instituto do Coração (InCor) do Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
| | | | | | | | | | | | | | | | | | - Bela Merkely
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | | | - Antonio Hernández-Madrid
- Unidad De Arritmias, Servicio De Cardiologia, Hospital Universitario Ramón y Cajal, Madrid, Spain
| | | | | | | | - Manlio F Marquez
- Departamento de Electrocardiología, Instituto Nacional de Cardiologia Ignacio Chavez, Tlalpan, Mexico
| | - David Haines
- Department of Cardiovascular Medicine, Beaumont Health System, Royal Oak, MI, USA
| | - Judith Mackall
- University Hospitals Case Medical Center, Cleveland, OH, USA
| | | | - Ugo Corra
- IRCCS Rehabilitation Medical Center, Cardiology Department, Salvatore Maugeri Foundation, Veruno, Italy
| | - Martin Halle
- Prevention and Sports Medicine, Technical University Munich, Munich, Germany
| | | | - Josef Niebauer
- Sports Medicine, Prevention & Rehabilitation, Paracelsus Medical University, Salzburg, Austria
| | | |
Collapse
|
17
|
Abstract
Although the occurrence of sudden cardiac death (SCD) in a young person is a rare event, it is traumatic and often widely publicized. In recent years, SCD in this population has been increasingly seen as a public health and safety issue. This review presents current knowledge relevant to the epidemiology of SCD and to strategies for prevention, resuscitation, and identification of those at greatest risk. Areas of active research and controversy include the development of best practices in screening, risk stratification approaches and postmortem evaluation, and identification of modifiable barriers to providing better outcomes after resuscitation of young SCD patients. Institution of a national registry of SCD in the young will provide data that will help to answer these questions.
Collapse
Affiliation(s)
- Michael Ackerman
- From Departments of Internal Medicine, Pediatrics, and Molecular Pharmacology & Experimental Therapeutics; Divisions of Cardiovascular Diseases and Pediatric Cardiology; Windland Smith Rice Sudden Death Genomics Laboratory; Mayo Clinic, Rochester, MN (M.A.);Stead Family Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa, City (D.L.A.); andDepartment of Cardiology, Boston Children's Hospital, MA (J.K.T.)
| | - Dianne L Atkins
- From Departments of Internal Medicine, Pediatrics, and Molecular Pharmacology & Experimental Therapeutics; Divisions of Cardiovascular Diseases and Pediatric Cardiology; Windland Smith Rice Sudden Death Genomics Laboratory; Mayo Clinic, Rochester, MN (M.A.);Stead Family Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa, City (D.L.A.); andDepartment of Cardiology, Boston Children's Hospital, MA (J.K.T.)
| | - John K Triedman
- From Departments of Internal Medicine, Pediatrics, and Molecular Pharmacology & Experimental Therapeutics; Divisions of Cardiovascular Diseases and Pediatric Cardiology; Windland Smith Rice Sudden Death Genomics Laboratory; Mayo Clinic, Rochester, MN (M.A.);Stead Family Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa, City (D.L.A.); andDepartment of Cardiology, Boston Children's Hospital, MA (J.K.T.).
| |
Collapse
|
18
|
Risgaard B, Tfelt-Hansen J, Winkel BG. Sports-related sudden cardiac death: How to prove an effect of preparticipation screening? Heart Rhythm 2016; 13:1560-2. [DOI: 10.1016/j.hrthm.2016.03.043] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/11/2016] [Indexed: 02/08/2023]
|
19
|
Harmon KG, Drezner JA, O'Connor FG, Asplund C, Finnoff JT. Should Electrocardiograms Be Part of the Preparticipation Physical Examination? PM R 2016; 8:S24-35. [PMID: 26972265 DOI: 10.1016/j.pmrj.2016.01.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2016] [Accepted: 01/07/2016] [Indexed: 12/23/2022]
Affiliation(s)
- Kimberly G Harmon
- Sports Medicine Section, Departments of Family Medicine and Orthopaedics and Sports Medicine, University of Washington, Sports Medicine Center at Husky Stadium UW Medicine, Seattle, WA(∗)
| | - Jonathan A Drezner
- Sports Medicine Section, Departments of Family Medicine and Orthopaedics and Sports Medicine, University of Washington, Sports Medicine Center at Husky Stadium UW Medicine, Seattle, WA(†)
| | - Francis G O'Connor
- Military and Emergency Medicine, Consortium for Health and Military Performance, Uniformed Services University of the Health Sciences, Bethesda, MD(‡)
| | - Chad Asplund
- Athletic Medicine, Health Services Division, Georgia Southern University, Statesboro, GA(§)
| | - Jonathan T Finnoff
- Department of Physical Medicine and Rehabilitation, Mayo Clinic College of Medicine, Rochester; and Mayo Clinic Sports Medicine Center, 600 Hennepin Ave, #310, Minneapolis, MN 55403(‖).
| |
Collapse
|
20
|
Stecker EC, Ayanian JZ, Fendrick AM. Value-Based Insurance Design: Aligning Incentives to Improve Cardiovascular Care. Circulation 2016; 132:1580-5. [PMID: 26481563 DOI: 10.1161/circulationaha.114.012584] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Eric C Stecker
- From Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR (E.C.S.); Institute for Healthcare Policy and Innovation, Division of General Medicine, Medical School and Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, MI (J.Z.A., A.M.F.); Gerald R. Ford School of Public Policy, University of Michigan, Ann Arbor, MI (J.Z.A.); and Center for Value-Based Insurance Design, School of Public Health and Medical School, University of Michigan, Ann Arbor, MI (A.M.F.).
| | - John Z Ayanian
- From Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR (E.C.S.); Institute for Healthcare Policy and Innovation, Division of General Medicine, Medical School and Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, MI (J.Z.A., A.M.F.); Gerald R. Ford School of Public Policy, University of Michigan, Ann Arbor, MI (J.Z.A.); and Center for Value-Based Insurance Design, School of Public Health and Medical School, University of Michigan, Ann Arbor, MI (A.M.F.)
| | - A Mark Fendrick
- From Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR (E.C.S.); Institute for Healthcare Policy and Innovation, Division of General Medicine, Medical School and Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, MI (J.Z.A., A.M.F.); Gerald R. Ford School of Public Policy, University of Michigan, Ann Arbor, MI (J.Z.A.); and Center for Value-Based Insurance Design, School of Public Health and Medical School, University of Michigan, Ann Arbor, MI (A.M.F.)
| |
Collapse
|
21
|
Electrocardiogram before starting stimulant medications: to order or not? Cardiol Young 2016; 26:216-9. [PMID: 26278960 DOI: 10.1017/s1047951115001274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
D is an 8-year-old boy brought to his paediatrician for evaluation. His mother is concerned as his teacher has been frequently complaining that he is very restless and often disturbs the rest of the class by getting up on some pretext or the other. He is unable to concentrate on his work and gets distracted very easily. He makes many careless mistakes and can hardly finish his tasks on time. He is frequently reprimanded for talking during class. He often answers out of turn or before the question has been completed; however, so far, he has been managing to get passing grades. At home, he is constantly on the go while he is awake. If he is forced to sit, like at mealtimes, he fidgets a lot. He also needs to be constantly nagged to do everything, even his daily activities such as brushing his teeth, or he forgets to do them or leaves them incomplete. He takes ages to finish his food. It is a major job to get him to do his homework. His mother says that at home he has been like that since the last 2 to 3 years, but now she is concerned because of the difficulties he is experiencing at school as well. After obtaining his medical history, examination, and getting response from parents and teachers--using Vanderbuilt Assessment Scales--the paediatrician diagnoses him to have attention deficit hyperactivity disorder. Besides behavioural interventions, he considers medications for his management. The paediatrician is debating the merits of performing electrocardiogram and/or referring the boy to a cardiologist before starting stimulant medications. If you were caring for this patient, how would you proceed?
Collapse
|
22
|
Spatial/Frontal QRS-T Angle Predicts All-Cause Mortality and Cardiac Mortality: A Meta-Analysis. PLoS One 2015; 10:e0136174. [PMID: 26284799 PMCID: PMC4540436 DOI: 10.1371/journal.pone.0136174] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2014] [Accepted: 07/31/2015] [Indexed: 01/01/2023] Open
Abstract
BACKGROUND A number of studies have assessed the predictive effect of QRS-T angles in various populations since the last decade. The objective of this meta-analysis was to evaluate the prognostic value of spatial/frontal QRS-T angle on all-cause death and cardiac death. METHODS PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials were searched from their inception until June 5, 2014. Studies reporting the predictive effect of spatial/frontal QRS-T angle on all-cause/cardiac death in all populations were included. Relative risk (RR) was used as a measure of effect. RESULTS Twenty-two studies enrolling 164,171 individuals were included. In the combined analysis in all populations, a wide spatial QRS-T angle was associated with an increase in all-cause death (maximum-adjusted RR: 1.40; 95% confidence interval [CI]: 1.32 to 1.48) and cardiac death (maximum-adjusted RR: 1.71; 95% CI: 1.54 to 1.90), a wide frontal QRS-T angle also predicted a higher rate of all-cause death (maximum-adjusted RR: 1.71; 95% CI: 1.54 to 1.90). Largely similar results were found using different methods of categorizing for QRS-T angles, and similar in subgroup populations such as general population, populations with suspected coronary heart disease or heart failure. Other stratified analyses and meta-analyses using unadjusted data also generated consistent findings. CONCLUSIONS Spatial QRS-T angle held promising prognostic value on all-cause death and cardiac death. Frontal QRS-T angle was also a promising predictor of all-cause death. Given the good predictive value of QRS-T angle, a combined stratification strategy in which QRS-T angle is of vital importance might be expected.
Collapse
|
23
|
Kaltman JR, Berul CI. Attention-Deficit Hyperactivity Disorder and Long-QT Syndrome: Risky Business. J Cardiovasc Electrophysiol 2015; 26:1045-7. [PMID: 26102514 DOI: 10.1111/jce.12744] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Jonathan R Kaltman
- Division of Cardiology, Children's National Medical Center, Washington, District of Columbia, USA.,Division of Cardiovascular Sciences, The National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA
| | - Charles I Berul
- Division of Cardiology, Children's National Medical Center, Washington, District of Columbia, USA
| |
Collapse
|
24
|
Student athletes, sudden cardiac death, and lifesaving legislation: a review of the literature. J Pediatr Health Care 2015; 29:233-42. [PMID: 25577720 DOI: 10.1016/j.pedhc.2014.11.006] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/02/2013] [Revised: 11/10/2014] [Accepted: 11/11/2014] [Indexed: 11/23/2022]
Abstract
PURPOSE The purpose of this article is to present findings of a literature review examining the use of automatic external defibrillators (AEDs) for student athletes experiencing sudden cardiac arrest and variances in state legislation regarding the mandatory placement of AEDs in school gymnasiums and athletic fields. METHODS A broad search of computerized databases was conducted utilizing PubMed, Medline, CINHAHL, and the Cochrane Databases, which provided a broad but not exhaustive review of the current literature related to student athletes, sudden cardiac death, and the use of AEDs. The articles were evaluated and graded using Stetler's strength of evidence guidelines. FINDINGS A total of 17 articles are included in this literature review (Stetler's Grade I, n = 1; Grade II, n = 2; Grade III, n =2; Grade IV, n = 5; Grade V, n = 3; and Grade VI, n = 4). The literature produced few meta-analyses of controlled studies, experimental studies, and quasi-experimental studies on the topic of student athletes at risk for sudden cardiac death. The majority of the literature is based on expert opinion, case reports, and retrospective data sets. The literature does support the correlation of early cardiopulmonary resuscitation and defibrillation with increased survival rates among persons experiencing sudden cardiac arrest. CONCLUSIONS Additional evidence-based research is needed to support the long-term outcomes of AED legislation and its utility in sparing the lives of student athletes. However, the evidence supporting early intervention, a coordinated emergency plan, and rapid emergency medical services response is conclusive enough to warrant state or federal legislation mandating that AEDs be present in all school gyms and athletic fields.
Collapse
|
25
|
Asif IM, Harmon KG. The Role of Screening for Sudden Cardiac Death in Young Competitive Athletes: A Critical Review. CURRENT PHYSICAL MEDICINE AND REHABILITATION REPORTS 2015. [DOI: 10.1007/s40141-014-0072-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
26
|
Vetter VL. Electrocardiographic screening of all infants, children, and teenagers should be performed. Circulation 2015; 130:688-97; discussion 697. [PMID: 25135125 DOI: 10.1161/circulationaha.114.009737] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Affiliation(s)
- Victoria L Vetter
- From The Children's Hospital of Philadelphia, and Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA.
| |
Collapse
|
27
|
Hammerness PG, Karampahtsis C, Babalola R, Alexander ME. Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks? Expert Opin Drug Saf 2015; 14:543-51. [PMID: 25648243 DOI: 10.1517/14740338.2015.1011620] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
INTRODUCTION This drug safety review provides an update on the long-term cardiovascular risks of therapeutic stimulant class medication for children and adults with attention-deficit/hyperactivity disorder (ADHD). AREAS COVERED Relevant literature on the long-term (defined as ≥ 12 months) cardiovascular effects of stimulant class medications for ADHD was sought using PubMed searches for clinical literature, epidemiological reports, as well as reviews of post-marketing data and clinical guidelines/consensus statements. Comparison was made to the non-stimulant atomoxetine. EXPERT OPINION Long-term cardiovascular risks of stimulants for healthy children and adults with ADHD are limited to minor mean elevations in blood pressure (≤ 7 mmHg) and heart rate (≤ 10 bpm). In a sizeable minority of individuals these elevations are greater and/or reach a clinical threshold. Subjective complaints may also be anticipated during long-term treatment, yet without an increase in serious cardiac outcomes above background rates per age. Future research is needed on possible latent or cumulative cardiovascular risks in healthy individuals, as well as the longer-term cardiovascular safety in vulnerable populations.
Collapse
|
28
|
Abstract
Adolescent sudden cardiac death is rare. When it occurs, it is devastating to families and communities because of the unexpected nature of the death and the age of the victim. It is especially troubling because these patients are seemingly healthy compared with their adult counterparts who die from coronary artery disease. This article reviews the incidence, etiology, prevalence, risk, screening, and prevention strategies for the sudden cardiac death of adolescents.
Collapse
|
29
|
Munshi K, Alexander ME, Hammerness P. Corrected QT interval changes with atypical antipsychotics. J Am Acad Child Adolesc Psychiatry 2015; 54:9-10. [PMID: 25524785 DOI: 10.1016/j.jaac.2014.10.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/24/2014] [Accepted: 10/30/2014] [Indexed: 11/19/2022]
|
30
|
Maron BJ, Friedman RA, Kligfield P, Levine BD, Viskin S, Chaitman BR, Okin PM, Saul JP, Salberg L, Van Hare GF, Soliman EZ, Chen J, Matherne GP, Bolling SF, Mitten MJ, Caplan A, Balady GJ, Thompson PD. Assessment of the 12-Lead ECG as a Screening Test for Detection of Cardiovascular Disease in Healthy General Populations of Young People (12–25 Years of Age). Circulation 2014; 130:1303-34. [DOI: 10.1161/cir.0000000000000025] [Citation(s) in RCA: 158] [Impact Index Per Article: 15.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
31
|
Maron BJ, Friedman RA, Kligfield P, Levine BD, Viskin S, Chaitman BR, Okin PM, Saul JP, Salberg L, Van Hare GF, Soliman EZ, Chen J, Matherne GP, Bolling SF, Mitten MJ, Caplan A, Balady GJ, Thompson PD. Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 2014; 64:1479-514. [PMID: 25234655 DOI: 10.1016/j.jacc.2014.05.006] [Citation(s) in RCA: 140] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
|
32
|
Vanhecke TE, Weber JE, Ebinger M, Bonzheim K, Tilli F, Rao S, Osman A, Silver M, Fliegner K, Almany S, Haines D. Implementation of ultraportable echocardiography in an adolescent sudden cardiac arrest screening program. CLINICAL MEDICINE INSIGHTS-CARDIOLOGY 2014; 8:87-92. [PMID: 25249762 PMCID: PMC4167321 DOI: 10.4137/cmc.s15779] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/31/2014] [Revised: 05/19/2014] [Accepted: 05/19/2014] [Indexed: 11/21/2022]
Abstract
BACKGROUND Over a 12-month period, adolescent heart-screening programs were performed for identifying at-risk adolescents for sudden cardiac death (SCD) in our community. Novel to our study, all adolescents received an abbreviated, ultraportable echocardiography (UPE). In this report, we describe the use of UPE in this screening program. METHODS AND RESULTS Four hundred thirty-two adolescents underwent cardiac screening with medical history questionnaire, physical examination, 12-lead electrocardiogram (ECG), and an abbreviated transthoracic echocardiographic examination. There were 11 abnormalities identified with uncertain/varying clinical risk significance. In this population, 75 adolescents had a murmur or high ECG voltage, of which only three had subsequent structural abnormalities on echocardiography that may pose risk. Conversely, UPE discovered four adolescents who had a cardiovascular structural abnormality that was not signaled by the 12-lead ECG, medical history questionnaire, and/or physical examination. CONCLUSIONS The utilization of ultraportable, handheld echocardiography is feasible in large-scale adolescent cardiovascular screening programs. UPE appears to be useful for finding additional structural abnormalities and for risk-stratifying abnormalities of uncertain potential of adolescents’ sudden death.
Collapse
Affiliation(s)
- Thomas E Vanhecke
- Department of Cardiovascular Medicine, Michigan State University/Genesys Regional Medical Center/Ascension Health, Grand Blanc, MI, USA
| | - James E Weber
- Department of Emergency Medicine, University of Michigan Medical School/Hurley Medical Center, Ann Arbor, MI, USA
| | - Matthew Ebinger
- Department of Cardiovascular Medicine, Michigan State University/Genesys Regional Medical Center/Ascension Health, Grand Blanc, MI, USA
| | - Kimberly Bonzheim
- Department of Cardiovascular Medicine, Michigan State University/Genesys Regional Medical Center/Ascension Health, Grand Blanc, MI, USA
| | - Frank Tilli
- Department of Cardiovascular Medicine, Michigan State University/Genesys Regional Medical Center/Ascension Health, Grand Blanc, MI, USA
| | - Sunilkumar Rao
- Department of Cardiovascular Medicine, Michigan State University/Genesys Regional Medical Center/Ascension Health, Grand Blanc, MI, USA
| | - Abdulfatah Osman
- Department of Cardiovascular Medicine, Michigan State University/Genesys Regional Medical Center/Ascension Health, Grand Blanc, MI, USA
| | - Marc Silver
- Department of Cardiovascular Medicine, Michigan State University/Genesys Regional Medical Center/Ascension Health, Grand Blanc, MI, USA
| | - Karsten Fliegner
- Department of Cardiovascular Medicine, Michigan State University/Genesys Regional Medical Center/Ascension Health, Grand Blanc, MI, USA
| | - Steve Almany
- Department of Cardiovascular Medicine, Oakland University/William Beaumont Hospital, Royal Oak, MI, USA
| | - David Haines
- Department of Cardiovascular Medicine, Oakland University/William Beaumont Hospital, Royal Oak, MI, USA
| |
Collapse
|
33
|
Drezner J, Harmon K, Toresdahl B. Reply to the editor--Incidence of sudden cardiac death in high school athletes: implications for cardiovascular screening. Heart Rhythm 2014; 11:e200-1. [PMID: 25168860 DOI: 10.1016/j.hrthm.2014.08.033] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/15/2014] [Indexed: 10/24/2022]
Affiliation(s)
- Jonathan Drezner
- Department of Family MedicineSports Medicine SectionUniversity of WashingtonSeattle, Washington.
| | - Kimberly Harmon
- Department of Family MedicineSports Medicine SectionUniversity of WashingtonSeattle, Washington
| | - Brett Toresdahl
- Primary Care Sports MedicineHospital of Special SurgeryNew York, New York
| |
Collapse
|
34
|
Abstract
OBJECTIVE Determine the cardiovascular screening practices of college team physicians. DESIGN Cross-sectional survey. SETTING Electronic mail with a link to a 9-item survey. PARTICIPANTS American Medical Society for Sports Medicine college team physicians. INTERVENTIONS Screening practices survey administered to college team physicians. MAIN OUTCOME MEASURES Cardiovascular preparticipation screening practices including noninvasive cardiac screening (NICS) such as electrocardiogram (ECG) or echocardiogram. RESULTS Two hundred twenty-four of 613 AMSSM members identifying themselves as college team physicians (36.5%) responded: National Collegiate Athletic Association Division I: 146, Division II: 41, Division III: 27, National Association of Intercollegiate Athletics: 8, and Junior College: 2. The majority (78%) of schools conducted the American Heart Association (AHA) 12-element history and physical examination. Division I institutions were more likely to add an ECG and/or echocardiogram (30%) to their preparticipation examination (PPE) compared with lower divisions (P < 0.0001). Those Division I schools using NICS were more likely to do so for all athletes (P < 0.001) or revenue generating sports (P < 0.001), whereas other institutions did so only for high-risk subgroups (P < 0.01). Lower division schools would consider adding ECG if it cost less (P = 0.01) or if there were more local expertise in athlete-specific interpretation standards (P = 0.04). CONCLUSIONS Many National Collegiate Athletic Association Athletes Division I programs already use NICS to screen athletes, whereas a significant portion of lower division schools add ECG for athletes deemed high risk. Increased use of these modalities suggests limitations of traditional PPE screening methods. CLINICAL RELEVANCE This is the first study to assess cardiac screening practices across all collegiate divisions and broadens our understanding of cardiac screening in high-level athletes.
Collapse
|
35
|
De Wolf D, Matthys D. Sports preparticipation cardiac screening: what about children? Eur J Pediatr 2014; 173:711-9. [PMID: 23775539 DOI: 10.1007/s00431-013-2064-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/05/2013] [Accepted: 06/05/2013] [Indexed: 10/26/2022]
Abstract
UNLABELLED Sudden cardiac death in young athletes is a devastating event. Screening programs have been proposed to prevent sudden cardiac death in young athletes. Mortality rates and causes of death differ among young adults and children. Children have a considerably lower incidence of sudden cardiac death. Data lack to compare athletes and non-athletes in childhood, but 40-50 % of sudden cardiac death in this age group seems to be related to exercise. Screening programs including history and physical exam are not very sensitive or specific and will result in important numbers of false-positives and false-negatives. Especially, interpretation of ECG in children is different from ECG in adults, with less accurate diagnoses as a consequence. Secondary prevention by widespread education of simple resuscitation techniques and use of automatic external defibrillators if available will probably save as many lives as any screening program. CONCLUSION Sufficient data are lacking to support general preparticipation screening with history, physical exam, and ECG in competitive children. Nevertheless, the impact of such a program, together with secondary preventive measures, should be evaluated in large prospective studies.
Collapse
Affiliation(s)
- Daniel De Wolf
- Department of Pediatric Cardiology, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium,
| | | |
Collapse
|
36
|
Asif IM, Johnson S, Schmieg J, Smith T, Rao AL, Harmon KG, Salerno JC, Drezner JA. The psychological impact of cardiovascular screening: the athlete's perspective. Br J Sports Med 2014; 48:1162-6. [DOI: 10.1136/bjsports-2014-093500] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
37
|
Risgaard B, Winkel BG, Jabbari R, Behr ER, Ingemann-Hansen O, Thomsen JL, Ottesen GL, Gislason GH, Bundgaard H, Haunsø S, Holst AG, Tfelt-Hansen J. Burden of Sudden Cardiac Death in Persons Aged 1 to 49 Years. Circ Arrhythm Electrophysiol 2014; 7:205-11. [DOI: 10.1161/circep.113.001421] [Citation(s) in RCA: 109] [Impact Index Per Article: 10.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background—
Knowledge of the burden and causes of sudden cardiac death (SCD) is sparse in persons aged <50 years; better understanding is needed to lower the risk of SCD. The aim of this study was to report SCD incidence rates and autopsy findings in persons aged 1 to 49 years.
Methods and Results—
All deaths in persons aged 1 to 49 years were included in 2007 to 2009. Death certificates were reviewed by 2 physicians. History of previous admissions to hospital was assessed, and discharge summaries were read. Sudden unexpected death cases were identified and autopsy reports were collected. In the 3-year study period, there were 7849 deaths of which we identified 893 (11%) SCD cases. The annual incidence rate per 100 000 persons increased from 2.3 (95% confidence interval, 2.0–2.7) to 21.7 (95% confidence interval, 20.2–23.4) in persons aged 1 to 35 and 36 to 49 years, respectively. Coronary artery disease was the most common cause of death and was found in 158 (36%) autopsied cases, followed by 135 (31%) cases of sudden unexplained death.
Conclusions—
In a nationwide cohort of persons aged <50 years, the annual incidence rate of SCD was ≈10× higher in persons aged 36 to 49 years than in persons aged 1 to 35 years. Notably, coronary artery disease was the most common cause of SCD, followed by unexplained deaths. These findings may help in developing strategies to prevent SCD in the future.
Collapse
Affiliation(s)
- Bjarke Risgaard
- From the Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC) (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), Laboratory of Molecular Cardiology (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), and Unit for Inherited Cardiac Diseases, Department of Cardiology (H.B.), The Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Cardiovascular Sciences Research Centre, St George’s University of London, London, United Kingdom (E.R.B.); Department of Forensic
| | - Bo Gregers Winkel
- From the Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC) (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), Laboratory of Molecular Cardiology (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), and Unit for Inherited Cardiac Diseases, Department of Cardiology (H.B.), The Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Cardiovascular Sciences Research Centre, St George’s University of London, London, United Kingdom (E.R.B.); Department of Forensic
| | - Reza Jabbari
- From the Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC) (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), Laboratory of Molecular Cardiology (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), and Unit for Inherited Cardiac Diseases, Department of Cardiology (H.B.), The Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Cardiovascular Sciences Research Centre, St George’s University of London, London, United Kingdom (E.R.B.); Department of Forensic
| | - Elijah R. Behr
- From the Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC) (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), Laboratory of Molecular Cardiology (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), and Unit for Inherited Cardiac Diseases, Department of Cardiology (H.B.), The Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Cardiovascular Sciences Research Centre, St George’s University of London, London, United Kingdom (E.R.B.); Department of Forensic
| | - Ole Ingemann-Hansen
- From the Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC) (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), Laboratory of Molecular Cardiology (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), and Unit for Inherited Cardiac Diseases, Department of Cardiology (H.B.), The Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Cardiovascular Sciences Research Centre, St George’s University of London, London, United Kingdom (E.R.B.); Department of Forensic
| | - Jørgen Lange Thomsen
- From the Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC) (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), Laboratory of Molecular Cardiology (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), and Unit for Inherited Cardiac Diseases, Department of Cardiology (H.B.), The Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Cardiovascular Sciences Research Centre, St George’s University of London, London, United Kingdom (E.R.B.); Department of Forensic
| | - Gyda Lolk Ottesen
- From the Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC) (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), Laboratory of Molecular Cardiology (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), and Unit for Inherited Cardiac Diseases, Department of Cardiology (H.B.), The Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Cardiovascular Sciences Research Centre, St George’s University of London, London, United Kingdom (E.R.B.); Department of Forensic
| | - Gunnar H. Gislason
- From the Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC) (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), Laboratory of Molecular Cardiology (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), and Unit for Inherited Cardiac Diseases, Department of Cardiology (H.B.), The Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Cardiovascular Sciences Research Centre, St George’s University of London, London, United Kingdom (E.R.B.); Department of Forensic
| | - Henning Bundgaard
- From the Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC) (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), Laboratory of Molecular Cardiology (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), and Unit for Inherited Cardiac Diseases, Department of Cardiology (H.B.), The Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Cardiovascular Sciences Research Centre, St George’s University of London, London, United Kingdom (E.R.B.); Department of Forensic
| | - Stig Haunsø
- From the Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC) (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), Laboratory of Molecular Cardiology (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), and Unit for Inherited Cardiac Diseases, Department of Cardiology (H.B.), The Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Cardiovascular Sciences Research Centre, St George’s University of London, London, United Kingdom (E.R.B.); Department of Forensic
| | - Anders Gaarsdal Holst
- From the Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC) (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), Laboratory of Molecular Cardiology (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), and Unit for Inherited Cardiac Diseases, Department of Cardiology (H.B.), The Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Cardiovascular Sciences Research Centre, St George’s University of London, London, United Kingdom (E.R.B.); Department of Forensic
| | - Jacob Tfelt-Hansen
- From the Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC) (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), Laboratory of Molecular Cardiology (B.R., B.G.W., R.J., S.H., A.G.H., J.T.-H.), and Unit for Inherited Cardiac Diseases, Department of Cardiology (H.B.), The Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Cardiovascular Sciences Research Centre, St George’s University of London, London, United Kingdom (E.R.B.); Department of Forensic
| |
Collapse
|
38
|
Electrocardiographic screening for hypertrophic cardiomyopathy and long QT syndrome: the drivers of cost-effectiveness for the prevention of sudden cardiac death. Pediatr Cardiol 2014; 35:323-31. [PMID: 24005901 DOI: 10.1007/s00246-013-0779-0] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/06/2013] [Accepted: 08/14/2013] [Indexed: 10/26/2022]
Abstract
It is universally recognized that the prevention of sudden cardiac death (SCD) in youth is an important public health initiative. The best approach remains uncertain. Many European and Asian countries support the use of electrocardiograms (ECGs). In the United States, this is highly controversial. Many debate its cost-effectiveness. We designed a comprehensive economic model of two of the most prevalent causes of SCD identifiable by ECG, hypertrophic cardiomyopathy (HCM) and long QT syndrome (LQTS), to determine the drivers of uncertainty in the estimate of cost-effectiveness. We compared the cost-effectiveness of screening with history and physical examination (H&P) plus ECG to the current United States standard, H&P alone, for the detection and treatment of HCM and LQTS. We used a Markov model on a theoretical cohort of healthy 12-year-olds over a 70-year time horizon from a societal perspective, employing extensive univariable and probabilistic sensitivity analyses, to determine drivers of costs and effectiveness. The incremental cost-effectiveness of adding ECGs to H&Ps was $41,400/life-year saved. The model was highly sensitive to the effect of identification and treatment of previously undiagnosed individuals with HCM; however, it was insensitive to many variables commonly assumed to be significant, including the costs of ECGs, echocardiograms, and genetic testing, as well as the sensitivity and specificity of ECGs. No LQTS-related parameters were significant. This study suggests that the key to determining the cost-effectiveness of ECG screening in the United States lies in developing a better understanding of disease progression in the previously undiagnosed HCM population.
Collapse
|
39
|
|
40
|
Kaltman JR, Burns KM, Pearson GD. Screening in pediatrics-more questions than answers? J Pediatr 2013; 162:454-6. [PMID: 23164312 DOI: 10.1016/j.jpeds.2012.10.020] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/15/2012] [Revised: 08/08/2012] [Accepted: 10/05/2012] [Indexed: 10/27/2022]
Affiliation(s)
- Jonathan R Kaltman
- Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD 20892, USA.
| | | | | |
Collapse
|
41
|
Kirsh JA. Finding the proverbial “needle in a haystack”: Identifying presymptomatic individuals with long QT syndrome. Heart Rhythm 2013; 10:239-40. [DOI: 10.1016/j.hrthm.2012.11.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/11/2012] [Indexed: 11/28/2022]
|
42
|
Earle N, Crawford J, Smith W, Hayes I, Shelling A, Hood M, Stiles M, Maxwell F, Heaven D, Love DR, Skinner JR. Community detection of long QT syndrome with a clinical registry: An alternative to ECG screening programs? Heart Rhythm 2013; 10:233-8. [DOI: 10.1016/j.hrthm.2012.10.043] [Citation(s) in RCA: 51] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/18/2012] [Indexed: 11/29/2022]
|
43
|
|
44
|
Dougherty KR, Friedman RA, Link MS, Estes NAM. Prediction and prevention of sudden death in young populations: the role of ECG screening. J Interv Card Electrophysiol 2012. [DOI: 10.1007/s10840-012-9755-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
45
|
Leslie LK, Rodday AM, Saunders TS, Cohen JT, Wong JB, Sheldrick RC, Parsons SK. Survey of United States child and adolescent psychiatrists' cardiac screening practices prior to starting patients on stimulants. J Child Adolesc Psychopharmacol 2012; 22:375-84. [PMID: 23083024 PMCID: PMC3482376 DOI: 10.1089/cap.2011.0141] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
OBJECTIVE The purpose of this study was to determine psychiatrists' barriers, attitudes, and practices regarding cardiac screening prior to initiating stimulants in children with attention-deficit/hyperactivity disorder. BACKGROUND Professional and federal oversight organizations recently have debated the evidence regarding sudden cardiac death (SCD) risk with stimulants, and have published guidelines recommending cardiac screening. It is not known how psychiatrists have responded. METHODS This study was a cross-sectional survey of 1,600 randomly-selected U.S. members of the American Academy of Child and Adolescent Psychiatry. Analyses included descriptive statistics and logistic regression. RESULTS Response rate was 40%; 96% met eligibility criteria. Barriers to identifying cardiac disorders in general included ability to perform a routine physical examination (74%) and care coordination with primary care providers (35%). Only 27% agreed that SCD risk warranted cardiac assessment. Prior to starting a patient on stimulants, 95% of psychiatrists obtained a routine history. The majority either conducted (9%), or relied on primary care providers to conduct (67%) a physical examination; 26% did not obtain a physical examination. Nineteen percent of psychiatrists ordered an electrocardiogram (ECG), of those, non-mutually exclusive reasons for ordering an ECG included standard practice procedure (62%), clinical findings (27%), medicolegal considerations (25%), and guideline adherence (24%). On multivariate modeling, psychiatrists were less likely to conduct cardiac screening themselves if in private practice (referent: academic medical center), if >50% of their patients had private insurance, or if they believed their ability to perform a physical examination to be a barrier. When modeling cardiac screening performed by any healthcare professional (e.g., psychiatrist, primary care practitioner), screening was less likely if the psychiatrist was practicing in a community mental health center (referent: academic medical center), was male, or if >50% of that psychiatrist's patients had private insurance. CONCLUSION Findings suggest the tacit interplay between primary care and psychiatry for the assessment and management of medical risks associated with psychotropic medications should be improved, and solutions prioritized.
Collapse
Affiliation(s)
- Laurel K. Leslie
- The Institute of Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.,Floating Hospital for Children, Tufts Medical Center, Boston, Massachusetts.,Tufts University School of Medicine, Boston, Massachusetts
| | - Angie Mae Rodday
- The Institute of Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts
| | - Tully S. Saunders
- The Institute of Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.,Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, Massachusetts
| | - Joshua T. Cohen
- The Institute of Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.,Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, Massachusetts
| | - John B. Wong
- Tufts University School of Medicine, Boston, Massachusetts
| | - R. Christopher Sheldrick
- The Institute of Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.,Department of Pediatrics, Tufts Medical Center, Boston, Massachusetts
| | - Susan K. Parsons
- The Institute of Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.,Floating Hospital for Children, Tufts Medical Center, Boston, Massachusetts.,Tufts University School of Medicine, Boston, Massachusetts
| |
Collapse
|
46
|
Koch S, Cassel M, Linné K, Mayer F, Scharhag J. ECG and echocardiographic findings in 10-15-year-old elite athletes. Eur J Prev Cardiol 2012; 21:774-81. [PMID: 23008134 DOI: 10.1177/2047487312462147] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
BACKGROUND Data on electrocardiographic and echocardiographic pre-participation screening findings in paediatric athletes are limited. METHODS AND RESULTS 10--15 year-old athletes (n = 343) were screened using electro- and echocardiography. The electrocardiogram (ECG) was normal in 220 (64%), mildly abnormal in 108 (31%), and distinctly abnormal in 15 (4%) athletes. Echocardiographic upper reference limits (URL, 97.5 percentile) for the left ventricular (LV) wall thickness in 10-11-year-old boys and girls were 9-10 mm and 8-9 mm, respectively; in 12-13-year-old boys and girls 9-10 mm; and in 14-15-year-old boys and girls 10-11 mm and 9-10 mm, respectively. Three athletes were excluded from competitive sports: one for symptomatic Wolff-Parkinson-White syndrome with a normal echocardiogram; one for negative T-waves in V1-V4 and a dilated right ventricle by echocardiography suggestive of (arrhythmogenic) right ventricular disease; and one for normal ECG and biscupid aortic valve including an aneurysm of the ascending aorta detected by echocardiography. Related to echocardiographic findings, the sensitivity and specificity of the ECG to identify cardiovascular abnormalities was 38% and 64%, respectively. The ECG's positive-predictive and negative-predictive values were 13% and 88%, respectively. The numbers needed to screen and calculated costs were 172 for ECG (€7049), 172 for echocardiography (€11,530), and 114 combining ECG and echocardiography (€9323). CONCLUSIONS Compared to adults, paediatric athletes presented with fewer distinctly abnormal ECGs, and there was no gender difference in paediatric athletes' ECG-pattern distribution. A combination of ECG and echocardiography for pre-participation screening of paediatric athletes is superior to ECG alone but 30% more costly.
Collapse
Affiliation(s)
- Sarah Koch
- University of Potsdam, Potsdam, Germany University of British Columbia, Vancouver, Canada
| | | | | | | | - Jürgen Scharhag
- University of Potsdam, Potsdam, Germany University of Heidelberg, Heidelberg, Germany
| |
Collapse
|
47
|
Carney EF. Pediatric ECG screening. Nat Rev Cardiol 2012; 9:373. [DOI: 10.1038/nrcardio.2012.76] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|